Expression of MMP-9 and IL-6 in patients with subarachnoid hemorrhage and the clinical significance
Authors:
Open Access
- 23 November 2017
- journal article
- research article
- Published by Spandidos Publications in Experimental and Therapeutic Medicine
- Vol. 15 (2) , 1510-1514
Abstract
The purpose of the present study was to investigate the expression of matrix metalloproteinase-9 (MMP-9) and interleukin-6 (IL-6) in patients with subarachnoid hemorrhage (SAH) and the clinical significance thereof. Forty-three patients with SAH and 23 healthy individuals were enrolled in this study. Patients were divided into the cerebral vasospasm (CVS) and non-cerebral vasospasm (non-CVS) groups, or the good and poor prognosis groups. Serum levels of MMP-9 and IL-6 were detected by ELISA. Expression levels of MMP-9 and IL-6 mRNAs were detected by RT‑qPCR. Expression levels of MMP-9 and IL-6 were elevated with the increase of grades as determined by the Hunt‑Hess grading method. Serum levels of MMP-9 and IL-6 in the CVS and poor prognosis groups were significantly higher than those in the control group. Expression levels of MMP-9 and IL-6 in the CVS group were significantly higher than those in the non-CVS group (P<0.05). Compared with the good prognosis group, the expression levels of MMP-9 and IL-6 were significantly increased in the poor prognosis group at 1, 4, 7 and 10 days after SAH (P<0.05). Additionally, the expression level of MMP-9 was significantly positively correlated with that of IL-6 (P<0.05). Expression levels of MMP-9 and IL-6 were significantly increased in patients with SAH, and the expression level of MMP-9 was positively correlated with that of IL-6. Thus, MMP-9 and IL-6 are involved in the development of SAH.Keywords
This publication has 20 references indexed in Scilit:
- Upregulation of tissue inhibitor of metalloproteinase-1 contributes to restoration of the extracellular matrix in the rabbit basilar artery during cerebral vasospasm after subarachnoid hemorrhageBrain Research, 2015
- Neuroprotective properties of dehydroepiandrosterone-sulfate and its relationship to interleukin 6 after aneurysmal subarachnoid hemorrhage: a prospective cohort studyCritical Care, 2015
- Characterisation of DWI-MRI confirmed cerebral infarcts in patients with subarachnoid haemorrhage and their association with MMP-9 levelsNeurological Research, 2015
- Blood–brain barrier permeability change and regulation mechanism after subarachnoid hemorrhageMetabolic Brain Disease, 2014
- Shunt-Dependent Hydrocephalus After Aneurysmal Subarachnoid Hemorrhage: The Role of Intrathecal Interleukin-6Neurocritical Care, 2014
- Adenosine dialdehyde suppresses MMP-9-mediated invasion of cancer cells by blocking the Ras/Raf-1/ERK/AP-1 signaling pathwayBiochemical Pharmacology, 2013
- Hydrogen sulfide deficiency and diabetic renal remodeling: role of matrix metalloproteinase-9American Journal of Physiology-Endocrinology and Metabolism, 2013
- Medical Management of Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage: A Review of Current and Emerging Therapeutic InterventionsNeurology Research International, 2013
- Systemic Interleukin-6 Levels Reflect Illness Course and Prognosis of Patients with Spontaneous Nonaneurysmal Subarachnoid Hemorrhage2012
- Potential Contribution of Hypoxia-Inducible Factor-1α, Aquaporin-4, and Matrix Metalloproteinase-9 to Blood–Brain Barrier Disruption and Brain Edema After Experimental Subarachnoid HemorrhageJournal of Molecular Neuroscience, 2012